Chief Financial Officer · Protara Therapeutics, Inc. (TARA)

Blaine Davis

A named executive officer of Protara Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,750,006

Salary $409,303Stock awards $0

FY2020: $3,383,602

3rd of 3 named executive officers at Protara Therapeutics by FY2021 total.

3 named officers on file for Protara Therapeutics, FY2021

Blaine Davis’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Protara Therapeutics’s whole pay program stands against its peers

  • Protara Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TARA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2022 (DEF 14A).

Free

Get Blaine Davis’s full pay file as a PDF — free

More than this page: up to 10 years of Blaine’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Blaine Davis compensation by year

Protara Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Protara Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$343,367$409,303
Bonus$0$0
Stock awards$0$0
Option awards$2,791,556$1,155,383
Non-equity incentive$236,390$170,837
Pension and deferred compensation$0$0
All other$12,289$14,483
Total$3,383,602$1,750,006

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Protara Therapeutics, Inc. DEF 14A filed April 27, 2022, accession 0001213900-22-021905, and prior-year filings.

How this page was built: the Protara Therapeutics, Inc. filed document, accession 0001213900-22-021905. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2022.

$3.4M
$1.8M
FY20
FY21
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option50,917—$37.30

Per the Outstanding Equity Awards at Fiscal Year-End table in Protara Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Protara Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Jesse SheffermanPresident, Chief Executive Officer and Director$4,068,661
Jacqueline ZummoChief Scientific Operations Officer$1,787,078
Blaine Davis · this pageChief Financial Officer$1,750,006

The full Protara Therapeutics compensation record

free company brief

This page is one person within Protara Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Protara Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Blaine Davis's compensation dossier · One-time report. No refunds.